Literature DB >> 1633838

Antibodies to cathepsin G in Crohn's disease.

W J Mayet1, E Hermann, J Finsterwalder, H Rieder, T Poralla, K H Meyer Zum Büschenfelde.   

Abstract

Antibodies directed against antigens in human neutrophils have proved to be of great diagnostic value in certain systemic vasculitides. Recent reports have focused the attention on these antigens as targets of antibodies in sera of patients with inflammatory bowel disease. We investigated the sera drawn from 60 patients suffering from biopsy proven Crohn's disease and 15 patients with active ulcerative colitis. Using sensitive enzyme-linked immunosorbent assays with purified antigens and Western blotting the following antibodies could be demonstrated: cathepsin G (cat-G) antibodies IgG 38.3%, IgM 13.3%, IgA 23.3% and antibodies against human leucocyte elastase (HLE) IgG, IgA, IgM 3.3%. Low but significant correlations could be found for cat-G antibodies (IgG) and the van HEES index of activity. 73.9% of the cat-G (IgG) positive patients had colon involvement. In the sera of patients with ulcerative colitis no antibodies to cat-G or HLE were detectable. Only 8.3% of the patients with Crohn's disease had antibodies against proteinase 3 (C-ANCA). Our data indicate that cat-G among other myeloid lysosomal enzymes seems to be an important target antigen of antibodies in sera of patients with Crohn's disease. Cat-G antibodies might be helpful to distinguish Crohn's disease from ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633838     DOI: 10.1111/j.1365-2362.1992.tb01485.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

Authors:  C Roozendaal; M H Zhao; G Horst; C M Lockwood; J H Kleibeuker; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates.

Authors:  A H Mulder; J Broekroelofs; G Horst; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

4.  Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells.

Authors:  W J Mayet; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

Authors:  W J Mayet; A Schwarting; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

6.  A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase.

Authors:  K M Dolman; I Damsma; A T Tool; A Sonnenberg; A E von dem Borne; R Goldschmeding
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

Review 7.  Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases.

Authors:  Kallirroi S Kyriakidi; Vasileios E Tsianos; Evaggelos Karvounis; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2016-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.